C07C 317/42
Y being a hetero atom
C07C317/42 (Y being a hetero atom) appears on 113 US grants and 78 published applications in this corpus.
Search patents in C07C- Granted patents
- 113
- Published applications
- 78
- Assignees
- 67
- Inventors
- 297
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 4 |
| 2003 | 4 | 8 |
| 2004 | 4 | 7 |
| 2005 | 5 | 3 |
| 2006 | 1 | 2 |
| 2007 | 3 | 4 |
| 2008 | 1 | 1 |
| 2009 | 1 | 3 |
| 2010 | 2 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 3 | 6 |
| 2014 | 4 | 3 |
| 2015 | 1 | 1 |
| 2016 | 3 | 4 |
| 2017 | 2 | 7 |
| 2018 | 8 | 4 |
| 2019 | 5 | 4 |
| 2020 | 3 | 3 |
| 2021 | 3 | 2 |
| 2022 | 2 | 4 |
| 2023 | 2 | 0 |
| 2024 | 3 | 4 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions and methods for the treatment of cancer24 Sep 2024US 12,098,117 B2Duke University
- Aryl ethers and uses thereof30 Apr 2024US RE49,948 E1Peloton Therapeutics, Inc.
- Cycloheptylamine derivatives as anti-diabetic agents6 Feb 2024US 11,891,348 B2United Arab Emirates University
- Cycloheptylamine derivatives as anti-diabetic agents1 Aug 2023US 11,713,290 B2United Arab Emirates University
- Polymorphic forms of N-(4-((4-(3-phenylureido)phenyl)sulfonyl)phenyl)benzolsulfonamide13 Jun 2023US 11,673,859 B2Koehler Paper SE
- Arylthio derivatives with pharmacological activity7 Aug 2025US 2025/0250229 A1Iridea S.R.L.
- Compositions and methods for the treatment of cancer12 Dec 2024US 2024/0409504 A1Duke University
- Compositions and methods for the treatment of cancer26 Sep 2024US 2024/0317727 A1Duke University
- 6-substituted naphthalene-1,3-disulfonic acid derivatives as modulators of the extracellular nicotinamide phosphoribosyl transferase (enampt) for the treatment of e.g. diabetes12 Sep 2024US 2024/0300968 A1The University of Manchester
- Amide derivatives of n-urea substituted amino acids as formyl peptidereceptor like-1 (fprl-1) receptor modulators29 Aug 2024US 2024/0285584 A1Allergan, Inc.
Most cited
By later US patents
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists88US 5,780,483 ASmithKline Beecham Corporation · 1998
- IL-8 receptor antagonists84US 6,005,008 ASmithKline Beecham Corporation · 1999
- IL-8 receptor antagonists76US 6,262,113 B1SmithKline Beecham Corporation · 2001
- Meta-substituted phenylene derivatives72US 5,773,646 AG. D. Searle & Co. · 1998